RT Journal Article
SR Electronic
T1 Obesity, old age, and frailty are the true risk factors for COVID-19 mortality and not chronic disease or ethnicity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.12.20156257
DO 10.1101/2020.08.12.20156257
A1 Zinu Philipose
A1 Nadia Smati
A1 Chun Shing Jefferson Wong
A1 Karen Aspey
A1 Michael Mendall
YR 2020
UL http://medrxiv.org/content/early/2020/11/18/2020.08.12.20156257.abstract
AB Coronavirus-19 (COVID-19) mortality in hospitalized patients is strongly associated with old age, nursing home residence, male sex and obesity, with a more controversial association with ethnicity and chronic diseases, in particular diabetes mellitus. Further complicating the evaluation of the independent impacts of these risk factors is the failure to control for frailty in published studies thus far.Aim To determine the independent risk factors for mortality in patients confirmed to have COVID-19 needing hospital admission and to evaluate the independence of these risk factors after adjusting for body mass index (BMI) and frailty.Methods This observational study retrospectively reviewed hospital electronic medical records of 466 consecutive patients admitted to Croydon University Hospital confirmed positive by rapid PCR test from 11th March to 9th April 2020. Statistical analysis was performed by multiple unconditional and univariate logistic regression.Results After multivariate analysis, male sex [OR 1.44 (CI 0.92-2.40)], age per year [OR 1.07 (CI 1.05-1.09)], morbid obesity (BMI > 40 kg/m2 vs BMI 18.5-24.9 kg/m2) [OR 14.8 (CI 5.25-41.8)], and nursing home residence (OR 3.01 (CI 1.56-5.79) were independently associated with COVID-19 mortality with no statistically significant association found with chronic diseases or ethnicity. BMI was associated with mortality throughout its range from underweight to morbidly obese OR 1.07(1.03-1.11) per kg/m2 increase, p=0.0002 In the non-nursing home population, after adjusting for age and sex, the OR for type 2 diabetes mellitus (T2DM) as a risk factor was 1.64 (CI 1.03-2.61, p = 0.03) attenuated to 1.30 (CI 0.78-2.18)) after controlling for BMI.; the association of mortality with male sex was strengthened [OR 1.66 (CI 0.96-2.87)] and that for ethnic minority patients was weakened [South Asians [from OR 1.30 (CI 0.67-2.53)) to OR 1.21 (CI 0.60-2.46)]; Afro Caribbean [from OR 1.24 (CI 0.65-2.34) to OR 1.16 (CI 0.58-2.30)]. There was a borderline but potentially large protective effect (p= 0.09) of anticoagulation drug use prior to admission [OR 0.56 (CI 0.28-1.11)].Conclusion No significant effect of ethnicity and chronic diseases as independent risk factors on COVID-19 mortality was found whereas male sex, high BMI, old age, and frailty were found to be independent risk factors. BMI was related to mortality risk throughout its range from underweight to severely obese. It is likely that chronic diseases are epiphenomena of the effects of ageing and visceral adiposity on the immune system. Routine prophylactic treatment with anticoagulant drugs in the high risk COVID-19 population warrants further prompt investigation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was not registered due to the nature of a novel disease i.e COVID-19 and to avoid any delay whilst waiting for trial approval keeping in mind, the urgency to inform the medical society of our findings.According to the guidelines of the UK Health Research Authority, as the data were collected as part of routine clinical care and were evaluated retrospectively, the study was considered a review of clinical practice and ethical approval was not required. This study was conducted in accordance with the Declaration of Helsinki Funding StatementNo funding was received for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research and Development department, Croydon University Hospital, CR7 7YEAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll our data is anonymized and available from a password protected secure location in keeping with the hospital trust guidelines and can be made available upon formal request.